Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.

about

Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.

Item

http://www.wikidata.org/entity/Q50054777

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@en

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@nl

type

Item

label

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@en

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@nl

prefLabel

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@en

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@nl

P1476

Hodgkin Lymphoma: Differences ...... ng Trends in Protocol Therapy.

@en

P2093

Maryann Bishop-Jodoin

http://www.w3.org/2001/XMLSchema#string

Thomas J FitzGerald

http://www.w3.org/2001/XMLSchema#string

P2860

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

The impact of protocol assignment for older adolescents with hodgkin lymphoma

P304

1179554918754885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1179554918754885

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434481

http://www.w3.org/2001/XMLSchema#string

P932

5802698

http://www.w3.org/2001/XMLSchema#string